215 related articles for article (PubMed ID: 11403176)
1. Salivary scintigraphy for assessing the protective effect of pilocarpine in head and neck irradiated tumours.
Mateos JJ; Setoain X; Ferre J; Rovirosa A; Navalpotro B; Martin F; Ortega M; Lomeña F; Fuster D; Pavia J; Pons F
Nucl Med Commun; 2001 Jun; 22(6):651-6. PubMed ID: 11403176
[TBL] [Abstract][Full Text] [Related]
2. [Usefulness of pilocarpine in the prevention of xerostomia in patients with head and neck cancer treated with radiotherapy. Assessment with gammagraphy and salivary flow].
Fuertes Cabero S; Setoain Perego X; Rovirosa Casino A; Mateos Fernández JJ; Fuster Pelfort D; Ferre Jorge J; Navalpotro Yagüe V; Paredes Barranco P; Ortín Pérez J; Muxí Pradas A; Pons Pons F
Rev Esp Med Nucl; 2004; 23(4):259-66. PubMed ID: 15207210
[TBL] [Abstract][Full Text] [Related]
3. Evidence for early and persistent impairment of salivary gland excretion after irradiation of head and neck tumours.
Liem IH; Olmos RA; Balm AJ; Keus RB; van Tinteren H; Takes RP; Muller SH; Bruce AM; Hoefnagel CA; Hilgers FJ
Eur J Nucl Med; 1996 Nov; 23(11):1485-90. PubMed ID: 8854847
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of oral pilocarpine in radiation-induced xerostomia in oropharyngeal carcinoma patients.
Kaur H; Singh Banipal RP; Singh H; Sonik YA; Sandhu SK
J Cancer Res Ther; 2023; 19(3):788-792. PubMed ID: 37470612
[TBL] [Abstract][Full Text] [Related]
5. Pilocarpine in the prevention of postirradiation xerostomia.
Lajtman Z; Krajina Z; Krpan D; Vincelj J; Borcić V; Popović-Kovacić J
Acta Med Croatica; 2000; 54(2):65-7. PubMed ID: 11028111
[TBL] [Abstract][Full Text] [Related]
6. Protection of salivary function by concomitant pilocarpine during radiotherapy: a double-blind, randomized, placebo-controlled study.
Burlage FR; Roesink JM; Kampinga HH; Coppes RP; Terhaard C; Langendijk JA; van Luijk P; Stokman MA; Vissink A
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):14-22. PubMed ID: 17869018
[TBL] [Abstract][Full Text] [Related]
7. Does salivary gland scintigraphy predict response to pilocarpine in patients with post-radiotherapy xerostomia?
Cooper RA; Cowan RA; Owens SE; Jeans SP; Roberts JK; Hillel PG; Slevin NJ; Allan E; Gupta NK; Collins CD
Eur J Nucl Med; 1999 Mar; 26(3):220-5. PubMed ID: 10079311
[TBL] [Abstract][Full Text] [Related]
8. Use of pilocarpine during head and neck radiation therapy to reduce xerostomia and salivary dysfunction.
Valdez IH; Wolff A; Atkinson JC; Macynski AA; Fox PC
Cancer; 1993 Mar; 71(5):1848-51. PubMed ID: 8448748
[TBL] [Abstract][Full Text] [Related]
9. A randomized study to assess the effectiveness of orally administered pilocarpine during and after radiotherapy of head and neck cancer.
Nyárády Z; Németh A; Bán A; Mukics A; Nyárády J; Ember I; Olasz L
Anticancer Res; 2006; 26(2B):1557-62. PubMed ID: 16619571
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy.
Münter MW; Karger CP; Hoffner SG; Hof H; Thilmann C; Rudat V; Nill S; Wannenmacher M; Debus J
Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):175-84. PubMed ID: 14697436
[TBL] [Abstract][Full Text] [Related]
11. Pilocarpine treatment of xerostomia in head and neck patients.
Leek H; Albertsson M
Micron; 2002; 33(2):153-5. PubMed ID: 11567884
[TBL] [Abstract][Full Text] [Related]
12. Randomized double blind, placebo-controlled study of pilocarpine administered during head and neck irradiation to reduce xerostomia.
Sangthawan D; Watthanaarpornchai S; Phungrassami T
J Med Assoc Thai; 2001 Feb; 84(2):195-203. PubMed ID: 11336078
[TBL] [Abstract][Full Text] [Related]
13. Scintigraphic assessment of salivary function and excretion response in radiation-induced injury of the major salivary glands.
Valdés Olmos RA; Keus RB; Takes RP; van Tinteren H; Baris G; Hilgers FJ; Hoefnagel CA; Balm AJ
Cancer; 1994 Jun; 73(12):2886-93. PubMed ID: 8199984
[TBL] [Abstract][Full Text] [Related]
14. Effect of pilocarpine during radiation therapy: results of RTOG 97-09, a phase III randomized study in head and neck cancer patients.
Scarantino C; LeVeque F; Swann RS; White R; Schulsinger A; Hodson DI; Meredith R; Foote R; Brachman D; Lee N
J Support Oncol; 2006 May; 4(5):252-8. PubMed ID: 16724649
[TBL] [Abstract][Full Text] [Related]
15. Double-blind randomized, placebo-controlled study of pilocarpine to salvage salivary gland function during radiotherapy of patients with head and neck cancer.
Gornitsky M; Shenouda G; Sultanem K; Katz H; Hier M; Black M; Velly AM
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Jul; 98(1):45-52. PubMed ID: 15243470
[TBL] [Abstract][Full Text] [Related]
16. Natural history and prevention of radiation injury.
O'Connell AC
Adv Dent Res; 2000 Dec; 14():57-61. PubMed ID: 11842925
[TBL] [Abstract][Full Text] [Related]
17. Systemic pilocarpine for treatment of xerostomia.
Berk L
Expert Opin Drug Metab Toxicol; 2008 Oct; 4(10):1333-40. PubMed ID: 18798702
[TBL] [Abstract][Full Text] [Related]
18. The effect of amifostine or IMRT to preserve the parotid function after radiotherapy of the head and neck region measured by quantitative salivary gland scintigraphy.
Rudat V; Münter M; Rades D; Grötz KA; Bajrovic A; Haberkorn U; Brenner W; Debus J
Radiother Oncol; 2008 Oct; 89(1):71-80. PubMed ID: 18707782
[TBL] [Abstract][Full Text] [Related]
19. Parasympathomimetic drugs for the treatment of salivary gland dysfunction due to radiotherapy.
Davies AN; Thompson J
Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD003782. PubMed ID: 26436597
[TBL] [Abstract][Full Text] [Related]
20. Changes in salivary gland function after radiotherapy of head and neck tumors measured by quantitative pertechnetate scintigraphy: comparison of intensity-modulated radiotherapy and conventional radiation therapy with and without Amifostine.
Münter MW; Hoffner S; Hof H; Herfarth KK; Haberkorn U; Rudat V; Huber P; Debus J; Karger CP
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):651-9. PubMed ID: 17175118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
